Literature DB >> 25542428

Bergenin decreases the morphine-induced physical dependence via antioxidative activity in mice.

Jaesuk Yun1, Yeonju Lee, Kyunghwa Yun, Seikwan Oh.   

Abstract

Oxidative stress plays a role in the development of physical dependence induced by morphine. Bergenin, a polyphenol found in many Asian, African, and South American medicinal plants, is a potent antinarcotic agent with wide spectrum of pharmacological activities including antioxidant action. In the present study, we observed that bergenin decreased the development of physical dependence induced by morphine in mice and the antioxidant activity of bergenin plays a role in the antinarcotic effects through adapting to morphine-induced oxidative stress in the brain. The naloxone-precipitated withdrawal symptom (jumping frequency) was significantly ameliorated (50% of control group) by administration of bergenin (20 mg/kg) in morphine-treated mice. Furthermore, morphine-induced down-regulation of glutathione (GSH) contents was reversed by bergenin administration in the frontal cortex and liver. Bergenin had no effects on the increased levels of nfr2-dependent antioxidant enzyme HO1 and NQO1 in the frontal cortex, striatum, and liver of morphine-treated mice. However, the morphine-induced increase in nrf2 nuclear translocation in the frontal cortex and striatum was inhibited by bergenin treatment. These results suggest that bergenin has a potential antinarcotic effect via regulation of GSH contents and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25542428     DOI: 10.1007/s12272-014-0534-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  6 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

2.  Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine.

Authors:  Junchao Tong; Paul S Fitzmaurice; Anna Moszczynska; Gausiha Rathitharan; Lee-Cyn Ang; Jeffrey H Meyer; Romina Mizrahi; Isabelle Boileau; Yoshiaki Furukawa; Tina McCluskey; Napapon Sailasuta; Stephen J Kish
Journal:  Drug Alcohol Depend       Date:  2018-06-23       Impact factor: 4.492

3.  Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway.

Authors:  Shihao Xiang; Kan Chen; Ling Xu; Ting Wang; Chuanyong Guo
Journal:  Drug Des Devel Ther       Date:  2020-01-13       Impact factor: 4.162

4.  Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.

Authors:  Huan Liu; Wei Zhang; Xiao-Dong Deng; Ying Ma; Yun Liu
Journal:  Mol Genet Genomic Med       Date:  2021-09-01       Impact factor: 2.183

5.  Protective Effect of Bergenin against Cyclophosphamide-Induced Immunosuppression by Immunomodulatory Effect and Antioxidation in Balb/c Mice.

Authors:  Qiuchen Qi; Zhonghua Dong; Yueyue Sun; Siying Li; Zhongxi Zhao
Journal:  Molecules       Date:  2018-10-17       Impact factor: 4.411

6.  Bergenin Reduces Experimental Painful Diabetic Neuropathy by Restoring Redox and Immune Homeostasis in the Nervous System.

Authors:  Cristiane F Villarreal; Dourivaldo S Santos; Pedro S S Lauria; Kelly B Gama; Renan F Espírito-Santo; Paulo J L Juiz; Clayton Q Alves; Jorge M David; Milena B P Soares
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.